Hirofumi Kogure Selected Research

Cholecystitis

10/2020	Endoscopic ultrasound-guided gallbladder drainage with a combined internal and external drainage tubes for acute cholecystitis.
8/2020	Lenvatinib-induced acute acalculous cholecystitis in a patient with hepatocellular carcinoma.
1/2016	Cholecystectomy after endoscopic papillary balloon dilation for bile duct stones reduced late biliary complications: a propensity score-based cohort analysis.
1/2014	Metallic stent with high axial force as a risk factor for cholecystitis in distal malignant biliary obstruction.
12/2012	Role of intervention for biliary and gastric/intestinal obstruction in gastric cancer with peritoneal metastasis.
4/2009	Management of late biliary complications in patients with gallbladder stones in situ after endoscopic papillary balloon dilation.
4/2009	Management of late biliary complications in patients with gallbladder stones in situ after endoscopic papillary balloon dilation.
11/2008	Efficacy and safety of metallic stents in patients with unresectable pancreatic cancer receiving gemcitabine.
7/2008	Intraductal US in the assessment of tumor involvement to the orifice of the cystic duct by malignant biliary obstruction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hirofumi Kogure Research Topics

Disease

35	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2008
23	Neoplasms (Cancer) 01/2022 - 01/2008
21	Pathologic Constriction (Stenosis) 06/2021 - 10/2006
16	Biliary Tract Neoplasms (Biliary Tract Cancer) 10/2020 - 01/2009
9	Cholecystitis 10/2020 - 07/2008
8	Cholangitis 02/2022 - 07/2007
7	Pancreatitis 11/2020 - 01/2011
7	Gastric Outlet Obstruction 09/2017 - 04/2012
6	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2010
6	Cholangiocarcinoma 12/2020 - 01/2008
5	Autoimmune Pancreatitis 02/2020 - 12/2007
4	Acute Cholecystitis 10/2020 - 04/2009
4	Diabetes Mellitus 02/2020 - 03/2013
4	Chronic Pancreatitis 01/2020 - 12/2007
3	Carcinoma (Carcinomatosis) 01/2021 - 01/2012
3	Exocrine Pancreatic Insufficiency 01/2018 - 09/2014
3	Sclerosing Cholangitis 10/2017 - 07/2010
3	Ascites 10/2016 - 09/2014
2	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 08/2020
2	Infections 02/2022 - 11/2008
2	Liver Failure 12/2021 - 01/2008
2	Neoplasms, Cystic, Mucinous, and Serous 01/2021 - 03/2014
2	Adenocarcinoma 01/2021 - 12/2012
2	Fistula 10/2020 - 09/2019
2	Glucose Intolerance 02/2020 - 07/2012
2	Fever (Fevers) 12/2018 - 12/2011
2	Cysts 12/2018 - 03/2014
2	Hypotension (Low Blood Pressure) 10/2013 - 08/2012
2	Gallbladder Neoplasms (Gallbladder Cancer) 04/2013 - 05/2010
2	Hyperlipidemias (Hyperlipidemia) 03/2013 - 07/2010
2	Neutropenia 01/2013 - 01/2009
1	Hepatitis 05/2022
1	Liver Diseases (Liver Disease) 05/2022
1	Pancreatic Fistula (Pancreatic Fistulas) 03/2021
1	Carcinogenesis 01/2021
1	Pancreatic Cyst 01/2021
1	Inflammation (Inflammations) 11/2020
1	Weight Loss (Weight Reduction) 08/2020
1	Drug-Related Side Effects and Adverse Reactions 08/2020
1	Acalculous Cholecystitis 08/2020

Drug/Important Bio-Agent (IBA)

29	Gemcitabine FDA Link 01/2021 - 01/2008
10	MetalsIBA 03/2021 - 09/2011
7	PlasticsIBA 03/2021 - 01/2009
6	Cisplatin (Platino)FDA LinkGeneric 09/2019 - 03/2011
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 12/2012
4	SteroidsIBA 02/2020 - 07/2012
3	Pharmaceutical PreparationsIBA 02/2022 - 01/2009
3	Anti-Bacterial Agents (Antibiotics)IBA 08/2020 - 12/2011
3	candesartanIBA 05/2015 - 08/2012
3	S 1 (combination)IBA 04/2013 - 05/2010
2	130-nm albumin-bound paclitaxelIBA 01/2021 - 01/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2020 - 03/2013
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 12/2019 - 11/2018
2	Leucovorin (Folinic Acid)FDA Link 09/2019 - 01/2019
2	Indicators and Reagents (Reagents)IBA 07/2019 - 01/2008
2	BilirubinIBA 12/2018 - 01/2009
2	BezafibrateIBA 10/2017 - 07/2010
2	C-Reactive ProteinIBA 06/2017 - 08/2010
2	Immunoglobulins (Immunoglobulin)IBA 04/2016 - 01/2012
2	AngiotensinsIBA 01/2016 - 05/2015
2	Amylases FDA Link 01/2014 - 10/2011
2	Risperidone (Risperdal Consta)FDA LinkGeneric 12/2013 - 08/2013
2	urinastatin (MR 20)IBA 12/2013 - 08/2013
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2013 - 01/2011
2	Irinotecan (Camptosar)FDA LinkGeneric 06/2013 - 01/2013
2	thiamine triphosphorate (TTP)IBA 01/2013 - 01/2008
2	Immunoglobulin E (IgE)IBA 01/2012 - 11/2010
1	InterferonsIBA 05/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2022
1	CytokinesIBA 05/2022
1	Suppressor of Cytokine Signaling ProteinsIBA 05/2022
1	Proteins (Proteins, Gene)FDA Link 05/2022
1	Proton Pump InhibitorsIBA 02/2022
1	Biological ProductsIBA 01/2022
1	ChromatinIBA 01/2022
1	pseudoginsenoside F11 (PF 11)IBA 03/2021
1	folfirinoxIBA 01/2021
1	ABO Blood-Group SystemIBA 01/2021
1	Blood Group Antigens (Blood Groups)IBA 01/2021
1	AcidsIBA 12/2020
1	protoporphyrin IXIBA 12/2020
1	lenvatinibIBA 08/2020
1	C-PeptideIBA 02/2020

Therapy/Procedure

35	Stents 06/2021 - 10/2006
24	Drug Therapy (Chemotherapy) 10/2020 - 01/2009
16	Therapeutics 02/2020 - 01/2009
14	Self Expandable Metallic Stents 05/2018 - 09/2011
9	Combination Drug Therapy (Combination Chemotherapy) 09/2019 - 01/2009
7	Liver Transplantation 12/2021 - 01/2008
5	Cholecystectomy 10/2020 - 04/2009
3	Endoscopic Sphincterotomy 05/2019 - 01/2011
2	Duration of Therapy 03/2021 - 10/2019
2	Laparoscopic Cholecystectomy 10/2020 - 05/2012
2	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 09/2019 - 01/2014
2	Enzyme Replacement Therapy 01/2018 - 01/2017
2	Catheters 07/2007 - 10/2006
1	Pancreaticojejunostomy 03/2021
1	Endoscopes 03/2021
1	Glycemic Control 08/2020